Bacterial contamination remains one of the major risks associated with blood product transfusion. The kinetics of bacterial growth in red blood cell concentrates (RBCC) is different than otherwise due to storage at 4°C, conditions in which most bacteria do not survive. Psychrophilic bacteria such as Yersinia enterocolitica, however, can proliferate from a very low level of contamination to clinically significant levels at 4°C and are known to cause severe transfusion-related infections. A screening method allowing the early detection of very low levels of bacteria in RBCC would improve transfusion safety. The Scansystem method has been previously described for detection of bacteria in platelet concentrates. We present here a modification of the system for detection of low levels of bacteria in RBCC. The Scansystem RBC kit protocol requires three steps, i.e., the agglutination and selective removal of RBCs, a labeling stage during which bacteria are labeled with a DNA-specific fluorophore, and finally recovery of bacteria on the surface of a black membrane for analysis using the Scansystem. The entire procedure from sampling to result can be completed in 90 min. Both gram-negative and gram-positive bacteria in RBCC are detected with a higher sensitivity than with currently available culture-based methods. The Scansystem RBC kit is shown to be sensitive enough to identify low-level bacterial contamination in a single unit tested in a pool of up to 20 RBCC samples (detection limit of between 1 and 10 CFU/ml depending on the bacterial strain). The method therefore lends itself to incorporation into high-sample-throughput screening programs.Due to the availability of highly sensitive virus screening kits, in donated blood products bacterial contamination, now the greatest risk for patients receiving a transfusion, is found 50 to 250 times more frequently than viral infection such as human immunodeficiency virus, hepatitis virus, or human T-cell lymphotropic virus infection. Transfusion-related bacterial infections are usually associated with a rapid onset of sepsis with high mortality rates (4, 16). Platelet concentrate preparations are known to carry a greater risk of bacterial infections, as they are required to be stored at 20 to 24°C (3, 6, 7, 10). With the significantly higher number of red blood cell concentrates (RBCC) transfused, however, the incidence of transfusionassociated bacterial contamination is similar (5,11,18,28). In the French Bacthem case-control study, 41 bacterium-related transfusion reactions were reported during a 2-year period, including 25 following transfusion with RBCC, with 4 fatalities, and 16 following platelet transfusion, with 2 fatalities (23).Currently, the examination of the RBCC bag for evidence of hemolysis just prior to transfusion is the only screening method carried out to check for bacterial contamination (12). However, visual inspection is subjective, and hemolysis also occurs in noncontaminated units nearing the end of their shelf life. Identification of low levels of bact...